MENU
APLS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Apellis Pharmaceuticals (APLS) Ownership - Who owns Apellis Pharmaceuticals?

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade... Show more

Profile

Industry
Medical Distributors
Address
100 Fifth Avenue
Phone
+1 617 977-5700
Employees
739
Web
https://www.apellis.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
5.25B
P/E Ratio
38.35
Total Cash
405.21M
Projected Growth
N/A
Total Debt
475.76M
Revenue
1.11B
Risk (Beta)
-1.10
Dividend Yield
N/A
Total Cash/Share
3.17
Total Debt/Equity
N/A
Revenue/Share
8.41 USD as % of share price
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a developer of therapeutics and drug delivery technologies to address chronic inflammatory diseases

Industry Biotechnology

Profile
Details
Industry
Medical Distributors
Address
100 Fifth Avenue
Phone
+1 617 977-5700
Employees
739
Web
https://www.apellis.com